| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.67 | 0.005 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.007 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.6 | 0.008 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.15 | 0.008 |